• Immunofluorescence analysis of U2OS cells using TXNL1 antibody (STJ28244). Blue: DAPI for nuclear staining.
  • Immunohistochemistry of paraffin-embedded rat brain using TXNL1 antibody (STJ28244) at dilution of 1:100 (40x lens).
  • Immunohistochemistry of paraffin-embedded human liver damage using TXNL1 antibody (STJ28244) at dilution of 1:100 (40x lens).
  • Immunohistochemistry of paraffin-embedded rat testis using TXNL1 antibody (STJ28244) at dilution of 1:100 (40x lens).
  • Western blot analysis of extracts of various cell lines, using TXNL1 antibody (STJ28244) at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 90s.

Anti-TXNL1 antibody (STJ28244)


Free Shipping
Current Stock:
Host: Rabbit
Applications: WB, IHC, IF
Reactivity: Human, Mouse, Rat
Short Description: Rabbit polyclonal anti-TXNL1 antibody is suitable for use in Western Blot, Immunohistochemistry and Immunofluorescence.
Clonality: Polyclonal
Conjugation: Unconjugated
Formulation: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Purification: Affinity purification
Storage Instruction: Store at-20°C. Avoid freeze/thaw cycles.
Isotype: IgG
Dilution Range: WB: 1:500-1:2000
IHC: 1:50-1:200
IF: 1:50-1:200
Gene ID: 9352
Gene Symbol: TXNL1
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-289 of human TXNL1 (NP_004777.1).
Function Active thioredoxin with a redox potential of about -250 mV.
Protein Name Thioredoxin-Like Protein 1
32 Kda Thioredoxin-Related Protein
Cellular Localisation Cytoplasm
At Least 85% Of The Cellular Txnl1 Is Proteasome-Associated
Alternative Antibody Names Anti-Thioredoxin-Like Protein 1 antibody
Anti-32 Kda Thioredoxin-Related Protein antibody
Anti-TXNL1 antibody
Anti-TRP32 antibody
Anti-TXL antibody
Anti-TXNL antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance